DOI: 10.1055/s-00000131

Synfacts

Referenz

Pierce ME. * Chen C.-y. * Tillyer RD. * et al. The DuPont Pharmaceuticals Company, Deepwater and Merck Research Laboratories, Rahway, USA
Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor.

J. Org. Chem. 1998;
63: 8536-8543

Bibliographische Angaben herunterladen

Aufrufen in: